SEARCH
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place to Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
FORTUNE 500
FORTUNE 500
FORTUNE SEA 500
Fortune 500 Europe
Fortune Global 500
Fortune China 500
Great Place to Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Banking
Investing
Crypto
Leadership
Leadership
Success
Future of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
sanofi
sanofi
Commentary
Sanofi CEO: AI might beat IQ, not EQ — but never say never
By
Paul Hudson
September 2, 2025
Health
Why Chrissy Teigen is speaking out about her 6-year-old’s Type 1 diabetes diagnosis
By
Beth Greenfield
April 28, 2025
Tech
Sanofi’s chief digital officer says remote work means employees lose the ‘serendipity’ needed to innovate
By
Ryan Hogg
March 27, 2025
Finance
L’Oreal sells €3 billion of Sanofi stock back to drugmaker
By
Phil Serafino
,
Angelina Rascouet
and
Bloomberg
February 3, 2025
Health
Olympian Jordan Chiles is setting her sights on a new goal: raising awareness of type 1 diabetes
By
Mahnoor Khan
December 26, 2024
Health
Polio is a deadly disease with a vaccine that RFK Jr.’s adviser wants to ban. Here’s how the immunization works
By
Lindsey Leake
December 13, 2024
Newsletters
Sanofi CEO Paul Hudson takes inspiration from ‘Fight Club’ to get his team hooked on AI
By
Ryan Hogg
November 27, 2024
Newsletters
Here’s what the top business leaders are saying about AI: ‘You need to be prepared for anything’
By
Emma Burleigh
November 15, 2024
Finance
Sanofi profit lifted by early vaccine sales, dupixent growth
By
Ashleigh Furlong
,
Tim Loh
and
Bloomberg
October 25, 2024
Health
French government ‘must block the sale’ of Sanofi’s Doliprane painkiller to U.S. private equity, critics argue
By
Jurgen Hecker
,
Tom Barfield
and
AFP
October 22, 2024
Retail
France’s top-selling painkiller may be sold to the U.S. and is causing the nation a splitting headache
By
Jurgen Hecker
and
AFP
October 15, 2024
Leadership
Forget expensive coaches, Paul Hudson, CEO of Sanofi turns to his three children for advice: ‘Through their eyes I get a glimpse into what the future looks like for the next generation’
By
Peter Vanham
June 20, 2024
Newsletters
Sanofi’s CEO is giving OpenAI access to its data in the hope of developing drugs more quickly
By
Peter Vanham
and
Nicholas Gordon
May 29, 2024
Finance
Meet Europe’s answer to the ‘Magnificent 7’—the high-flying ‘Granolas’ that Goldman Sachs is betting will prosper in the continent’s flatlining economy
By
Ryan Hogg
March 3, 2024
Health
Minnesotans can buy insulin for just $35 a month over the next 5 years under a state settlement with Eli Lilly
By
Steve Karnowski
and
The Associated Press
February 8, 2024
Most Popular
AI
'Godfather of AI' says the technology will create massive unemployment and send profits soaring — 'that is the...
By
Jason Ma
Success
This Stanford computer science professor went to written exams 2 years ago because of AI. He says his students insisted...
By
Nick Lichtenberg
Health
RFK Jr.'s planned report linking Tylenol to autism crashes shares of parent company Kenvue
By
Ashley Lutz